ResMed Stock Quote Today

RMD
 Stock
  

USD 229.34  0.58  0.25%   

Market Performance
3 of 100
Odds Of Distress
Less than 1
ResMed is trading at 229.34 as of the 27th of November 2022, a -0.25% down since the beginning of the trading day. The stock's lowest day price was 228.56. ResMed has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for ResMed Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2022 and ending today, the 27th of November 2022. Click here to learn more.
CUSIP
761152107
Fiscal Year End
June
Business Domain
Health Care Equipment & Services
IPO Date
2nd of June 1995
Category
Healthcare
Classification
Health Care
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. The company has 145.72 M outstanding shares of which 1.23 M shares are at this time shorted by investors with about 2.79 days to cover. More on ResMed Inc
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

ResMed Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ResMed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ResMed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ResMed Inc is unlikely to experience financial distress in the next 2 years
ResMed Inc has a poor financial position based on the latest SEC disclosures
About 67.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Ronald Taylor of 1122 shares of ResMed subject to Rule 16b-3
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, ResMed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ResMed's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
CEOMichael Farrell
Thematic Ideas
(view all).
Excise Tax ActivitiesAnimal Testing
Average Analyst Recommendation
Analysts covering ResMed report their recommendations after researching ResMed's financial statements, talking to executives and customers, or listening in on ResMed's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering ResMed Inc. The ResMed consensus assessment is calculated by taking the average forecast from all of the analysts covering ResMed.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of ResMed Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of ResMed Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted162.3 M147 M
Significantly Up
Increasing
Stable
Weighted Average Shares160.5 M146.1 M
Significantly Up
Increasing
Slightly volatile
Return on Average Assets15.7415.8681
Slightly Down
Increasing
Very volatile
Net Cash Flow from Operations374.2 M351.1 M
Notably Up
Increasing
Slightly volatile
Current Liabilities562.1 M689.3 M
Significantly Down
Increasing
Slightly volatile
Total Liabilities1.4 B1.7 B
Significantly Down
Increasing
Slightly volatile
Gross Margin64.1256.5746
Moderately Up
Decreasing
Stable
Total Debt1.1 B1.1 B
Significantly Up
Increasing
Slightly volatile
Asset Turnover0.670.7284
Significantly Down
Increasing
Stable
Current Assets1.6 B1.9 B
Fairly Down
Increasing
Slightly volatile
Total Assets5.5 B5.1 B
Significantly Up
Increasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ResMed's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
ResMed's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to ResMed's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand ResMed's financial leverage. It provides some insight into what part of ResMed's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on ResMed's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how ResMed deploys its capital and how much of that capital is borrowed.
Liquidity
ResMed cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 917.55 M in debt with debt to equity (D/E) ratio of 0.27, which may show that the company is not taking advantage of profits from borrowing. ResMed Inc has a current ratio of 2.74, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist ResMed until it has trouble settling it off, either with new capital or with free cash flow. So, ResMed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ResMed Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ResMed to invest in growth at high rates of return. When we think about ResMed's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

374.22 Million
ResMed Inc (RMD) is traded on New York Stock Exchange in USA and employs 8,160 people. The company currently falls under 'Large-Cap' category with total capitalization of 33.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ResMed's market, we take the total number of its shares issued and multiply it by ResMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ResMed Inc runs under Healthcare sector within Medical Instruments & Supplies industry. The entity has 145.72 M outstanding shares of which 1.23 M shares are at this time shorted by investors with about 2.79 days to cover. ResMed Inc has about 273.71 M in cash with 351.15 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87.
Check ResMed Probability Of Bankruptcy
Ownership
ResMed Inc has a total of 145.72 Million outstanding shares. Over half of ResMed Inc outstanding shares are owned by third-party entities. These third-party entities are typically referred to corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in ResMed. Please watch out for any change in the institutional holdings of ResMed Inc as this could mean something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check ResMed Ownership Details

ResMed Stock Price Odds Analysis

What are ResMed's target price odds to finish over the current price? Based on a normal probability distribution, the odds of ResMed jumping above the current price in 90 days from now is about 13.71%. The ResMed Inc probability density function shows the probability of ResMed stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon ResMed has a beta of 0.8019 indicating as returns on the market go up, ResMed average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ResMed Inc will be expected to be much smaller as well. Additionally, the company has an alpha of 0.0055, implying that it can generate a 0.005492 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 229.34HorizonTargetOdds Above 229.34
86.09%90 days
 229.34 
13.71%
Based on a normal probability distribution, the odds of ResMed to move above the current price in 90 days from now is about 13.71 (This ResMed Inc probability density function shows the probability of ResMed Stock to fall within a particular range of prices over 90 days) .

ResMed Stock Institutional Holders

Institutional Holdings refers to the ownership stake in ResMed that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ResMed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ResMed's value.
InstituionSecurity TypeTotal SharesValue
Zweigdimenna Associates LlcCommon Shares4.7 K221 K
Zurich Insurance Group LtdCommon Shares235.3 K49.3 M
View ResMed Diagnostics

ResMed Historical Income Statement

ResMed Inc Income Statement is one of the three primary financial statements used for reporting ResMed's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of ResMed Inc revenue and expense. ResMed Income Statement primarily focuses on the company's revenues and expenses during a particular period.
ResMed Consolidated Income is projected to increase significantly based on the last few years of reporting. The past year's Consolidated Income was at 317.17 Million. The current year Cost of Revenue is expected to grow to about 749.9 M, whereas Selling General and Administrative Expense is forecasted to decline to about 347.3 M. View More Fundamentals

ResMed Stock Against Markets

Picking the right benchmark for ResMed stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ResMed stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ResMed is critical whether you are bullish or bearish towards ResMed Inc at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ResMed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Recommendations Now

   

Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

ResMed Corporate Directors

ResMed corporate directors refer to members of a ResMed board of directors. The board of directors generally takes responsibility for the ResMed's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ResMed's board members must vote for the resolution. The ResMed board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
John Wareham - Independent DirectorProfile
Ronald Taylor - Lead Independent DirectorProfile
Gary Pace - Independent DirectorProfile
Agnes Lee - Senior Director - Investor RelationsProfile

Invested in ResMed Inc?

The danger of trading ResMed Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ResMed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ResMed. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ResMed Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at Your Equity Center. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for analysis

When running ResMed Inc price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.029
Market Capitalization
33.7 B
Quarterly Revenue Growth YOY
0.051
Return On Assets
0.13
Return On Equity
0.24
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine ResMed value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.